LENZ Therapeutics, Inc.
LENZ
$4.73
$0.132.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -114.04% | -183.80% | -183.72% | -63.49% | -45.43% |
| Total Depreciation and Amortization | 478.95% | 208.33% | 328.00% | 1,150.00% | 5.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.63% | 193.88% | 393.27% | 223.32% | 174.76% |
| Change in Net Operating Assets | -789.09% | 213.78% | -110.79% | 538.49% | 126.34% |
| Cash from Operations | -236.40% | -109.25% | -263.79% | 18.84% | 27.14% |
| Capital Expenditure | 93.33% | 83.64% | 74.50% | -136.02% | -80.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21,806.90% | 74.64% | -666.37% | 93.72% | 99.82% |
| Cash from Investing | 9,219.32% | 75.56% | -657.06% | 93.04% | 99.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.51% | -68.18% | 231,249.06% | -98.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.51% | -68.18% | 231,249.06% | -97.99% | 1,339.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.87% | -114.11% | 98.95% | 71.33% | 112.52% |